|
| ID |
DDInter262 |
| Drug Type |
small molecule |
| Molecular Formula |
C28H24Fn3O5 |
| Molecular Weight |
501.514
|
| Description |
Cabozantinib is a tyrosine kinase inhibitor used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer.
|
| ATC Classification |
L01XE26
|
| IUPAC Name |
N'1-{4-[(6,7-Dimethoxyquinolin-4-Yl)Oxy]Phenyl}-N1-(4-Fluorophenyl)Cyclopropane-1,1-Dicarboxamide |
| InChI |
Inchi=1S/C28H24Fn3O5/C1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/H3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34) |
| InChI Key |
ONIQOQHATWINJY-UHFFFAOYSA-N |
| Canonical SMILES |
COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|